Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Top Publications
Garland, SM.
The Australian Experience With the Human Papillomavirus Vaccine.
Clinical Therapeutics
36(1)
:
17 -23
2014
view publication
Jacobs, SE, Tobin, JM, Opie, GF, Donath, S, Tabrizi, SN, Pirotta, M, Morley, CJ, Garland, SM.
Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled Trial.
Pediatrics
132(6)
:
1055 -1062
2013
view publication
Young, EJ, Tabrizi, SN, Brotherton, JM, Wark, JD, Pyman, J, Saville, M, Wrede, CD, Jayasinghe, Y, Tan, J, Gertig, DM, et al.
Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study).
BMC Cancer
13(1)
:
296
2013
view publication
Machalek, DA, Grulich, AE, Hillman, RJ, Jin, F, Templeton, DJ, Tabrizi, SN, Garland, SM, Prestage, G, McCaffery, K, Howard, K, et al.
The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study.
BMC Public Health
13(1)
:
946
2013
view publication
Tobin, JM, Garland, SM, Jacobs, SE, Pirotta, M, Tabrizi, SN.
Rapid assay to assess colonization patterns following in-vivo probiotic ingestion.
BMC Research Notes
6(1)
:
252
2013
view publication